These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3863130)

  • 41. 3-Phosphonopropionic acids inhibit carboxypeptidase A as multisubstrate analogues or transition-state analogues.
    Grobelny D; Goli UB; Galardy RE
    Biochem J; 1985 Nov; 232(1):15-9. PubMed ID: 4084224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.
    Reverter D; Fernández-Catalán C; Baumgartner R; Pfänder R; Huber R; Bode W; Vendrell J; Holak TA; Avilés FX
    Nat Struct Biol; 2000 Apr; 7(4):322-8. PubMed ID: 10742178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
    Park JD; Kim DH
    Bioorg Med Chem; 2004 May; 12(9):2349-56. PubMed ID: 15080932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphology of the procarboxypeptidase A-S6 complex. A solution X-ray scattering study.
    Kerfelec B; Chapus C; Vachette P
    Eur Biophys J; 1988; 16(2):95-100. PubMed ID: 3208711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptidic mechanism-based inactivators for carboxypeptidase A.
    Ghosh SS; Wu YQ; Mobashery S
    J Biol Chem; 1991 May; 266(14):8759-64. PubMed ID: 2026592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The enzymatic mechanism of carboxypeptidase: a molecular dynamics study.
    Banci L; Bertini I; La Penna G
    Proteins; 1994 Feb; 18(2):186-97. PubMed ID: 8159667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 19F nuclear magnetic resonance spectroscopy study of the complex of 2-benzyl-4-oxo-5,5,5-trifluoropentanoic acid and carboxypeptidase A.
    Teater C; Grobelny D; Galardy RE
    Biochem Biophys Res Commun; 1988 Jun; 153(2):773-8. PubMed ID: 3382403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative modeling of substrate binding in the S1' subsite of serine carboxypeptidases from yeast, wheat, and human.
    Elsliger MA; Pshezhetsky AV; Vinogradova MV; Svedas VK; Potier M
    Biochemistry; 1996 Nov; 35(47):14899-909. PubMed ID: 8942654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carboxypeptidase inhibitor from potatoes. Interaction with derivatives of carboxypeptidase A.
    Ako H; Hass GM; Grahn DT; Neurath H
    Biochemistry; 1976 Jun; 15(12):2573-8. PubMed ID: 938626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. pK values for active site residues of carboxypeptidase A.
    Mock WL; Tsay JT
    J Biol Chem; 1988 Jun; 263(18):8635-41. PubMed ID: 3379037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spectral titration of active site of carboxypeptidase A.
    Suh J; Hwang BK; Jang I; Oh E
    J Biochem Biophys Methods; 1991; 22(2):167-70. PubMed ID: 2061563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A.
    Ghosh SS; Dakoji S; Tanaka Y; Cho YJ; Mobashery S
    Bioorg Med Chem; 1996 Sep; 4(9):1487-92. PubMed ID: 8894106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ligand binding of bovine carboxypeptidase B. IV. Oligopeptide substrates and extended active center.
    Sukenaga Y; Akanuma H; Yamasaki M
    J Biochem; 1980 Jun; 87(6):1691-701. PubMed ID: 7400117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluxionate Lewis acidity of the Zn2+ ion in carboxypeptidase A.
    Mock WL; Freeman DJ; Aksamawati M
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):185-93. PubMed ID: 8424757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the hydrolytic properties of (serine) carboxypeptidase Y.
    Stennicke HR; Mortensen UH; Breddam K
    Biochemistry; 1996 Jun; 35(22):7131-41. PubMed ID: 8679540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for the general base mechanism in carboxypeptidase A-catalyzed reactions: partitioning studies on nucleophiles and H2(18)O kinetic isotope effects.
    Breslow R; Chin J; Hilvert D; Trainor G
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4585-9. PubMed ID: 6576353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The 4.5 A resolution structure analysis of the exocellular DD-carboxypeptidase of Streptomyces albus G.
    Dideberg O; Charlier P; Dupont L; Vermeire M; Frere JM; Ghuysen JM
    FEBS Lett; 1980 Aug; 117(1):212-4. PubMed ID: 7409166
    [No Abstract]   [Full Text] [Related]  

  • 58. Similarities between the conformation of arsanilazotyrosine 248 of carboxypeptidase A in the crystalline state and in solution.
    Quiocho FA; McMurray CH; Lipscomb WN
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2850-4. PubMed ID: 4507609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three high-resolution crystal structures of cadmium-substituted carboxypeptidase A provide insight into the enzymatic function.
    Jensen F; Bukrinsky T; Bjerrum J; Larsen S
    J Biol Inorg Chem; 2002 Apr; 7(4-5):490-9. PubMed ID: 11941507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optically active 2-benzyl-3-methanesulfinylpropanoic acid: Synthesis and evaluation as inhibitors for carboxypeptidase A.
    Jin JY; Tian GR; Kim DH
    Bioorg Med Chem; 2003 Oct; 11(20):4377-81. PubMed ID: 13129575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.